HUMBERTO DORTA: Open Payments
NPI 1629044128 · MEADVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,443 in 100 payments from 14 companies in 2025. Trend: 2023 $1,288 · 2024 $1,206 · 2025 $1,443
Food & beverage: $1,443
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 23 | $256 |
| Teva Pharmaceuticals USA, Inc. | 25 | $213 |
| Alkermes, Inc. | 12 | $197 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $171 |
| Janssen Pharmaceuticals, Inc | 6 | $138 |
| E.R. Squibb & Sons, L.L.C. | 5 | $92 |
| Novo Nordisk Inc | 4 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $69 |
| Lundbeck LLC | 3 | $61 |
| Vanda Pharmaceuticals Inc. | 2 | $46 |
Products named: Auvelity, ARISTADA, CAPLYTA, AUSTEDO XR, INVEGA SUSTENNA, REXULTI, COBENFY, Wegovy.
Industry payments across PA — which companies pay providers there.
